Nab-Paclitaxel + Cisplatin + Gemcitabine + TTF in pt. w/ Metastatic PAC

Clinical trial NCT04605913 · RECRUITING

Trial details

NCT number: NCT04605913
Sponsor: Mayo Clinic
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Pancreas Cancer Metastatic Pancreatic Cancer Pancreatic Adenocarcinoma Metastatic Adenocarcinoma

Start date: 2022-04-01
Primary completion: 2027-10-01
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.